Skip to Main Content

Author Details

Parambir S Dulai
Feinberg School of Medicine Northwestern University
2011
216
41
PMIDPaper TitleJournal TitlePublished Year
37224287Safety and Effectiveness of Vedolizumab in Elderly Patients with Inflammatory Bowel Disease: A Systematic Review & Meta-Analysis.J Clin Gastroenterol2024
37949249Integrating Evidence to Guide Use of Biologics and Small Molecules for Inflammatory Bowel Diseases.Gastroenterology2024
37783933Trends of inflammatory bowel disease from the Global Burden of Disease Study (1990-2019).Indian J Gastroenterol2024
37186256Matching-adjusted Indirect Comparisons vs Propensity Score Matching with Individual Patient-level Data to Estimate Treatment Efficacy.Inflamm Bowel Dis2024
37116893Predicting Endoscopic Improvement in Ulcerative Colitis Using the Ulcerative Colitis Severity Index.Inflamm Bowel Dis2024
36343846Comparative Safety and Effectiveness of Biologic Therapy for Crohn's Disease: A CA-IBD Cohort Study.Clin Gastroenterol Hepatol2023
37853256Author Correction: Enhancing untargeted metabolomics using metadata-based source annotation.Nat Biotechnol2023
37623370The importance of predicting patient responses to monoclonal antibodies for Crohn's disease.Expert Opin Biol Ther2023
35704691A Serum Biomarker Panel Can Accurately Identify Mucosal Ulcers in Patients With Crohn's Disease.Inflamm Bowel Dis2023
35644340Effectiveness and Safety of Biologic Therapy in Hispanic Vs Non-Hispanic Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study.Clin Gastroenterol Hepatol2023
35672039Correspondence on "PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence system" by Gui <i>et al</i>.Gut2023
35762666The Performance of the Rutgeerts Score, SES-CD, and MM-SES-CD for Prediction of Postoperative Clinical Recurrence in Crohn's Disease.Inflamm Bowel Dis2023
37391059Delayed Ustekinumab Responders in Ulcerative Colitis Have Greater Inflammatory Burden but Similar Outcomes as Early Responders.Clin Gastroenterol Hepatol2023
37119375Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched Study.Dig Dis Sci2023
37268795Correlations Between Gastrointestinal Symptoms and Endoscopic-Histologic Disease Activity in Adults with Ulcerative Colitis.Dig Dis Sci2023
37300328Efficacy of biologic and small molecule agents as second-line therapy after exposure to TNF inhibitors in patients with ulcerative colitis: A propensity-matched cohort study.Aliment Pharmacol Ther2023
37265170Role of hyperbaric oxygen therapy in patients with inflammatory bowel disease.Curr Opin Gastroenterol2023
37261911Macrophage-endothelial cell crosstalk orchestrates neutrophil recruitment in inflamed mucosa.J Clin Invest2023
36645636Vedolizumab and Adalimumab in Biologic-Naïve Ulcerative Colitis: Comparison of Patient-Level Clinical Trial Data and VARSITY for Week 6 Clinical Remission.Dig Dis Sci2023
36426810Predictors of Clinical Remission to Placebo in Clinical Trials of Crohn's Disease.Inflamm Bowel Dis2023
36821429Combined Histological and Endoscopic Endpoints at Post-induction Lack Additional Prognostic Value Compared with Endoscopic Improvement Alone in Ulcerative Colitis: A Post hoc Analysis of the VARSITY study.J Crohns Colitis2023
35909369End of induction patient reported outcomes predict clinical remission and endoscopic improvement with vedolizumab and adalimumab in ulcerative colitis.Scand J Gastroenterol2023
36179118Ulcer Size After Induction Therapy Performs Better Than Symptom Assessment for Prediction of One Year Endoscopic Remission in Crohn's Disease: A Post Hoc Analysis.Inflamm Bowel Dis2023
35934286Prognostic Value of Fecal Calprotectin to Inform Treat-to-Target Monitoring in Ulcerative Colitis.Clin Gastroenterol Hepatol2023
36066459Long-Term Outcomes of Early vs Delayed Responders to Vedolizumab and Adalimumab: A Post Hoc Analysis of the VARSITY Study.Am J Gastroenterol2023
36029969Predictors of Placebo Induction Response and Remission in Ulcerative Colitis.Clin Gastroenterol Hepatol2023
36227009Baseline Patient-reported Symptoms Less Predictive Than MM-SES-CD for Endoscopic Remission in Crohn's Disease.J Clin Gastroenterol2023
35920382Comparative Efficacy of Infliximab vs Ustekinumab for Maintenance of Clinical Response in Biologic Naïve Crohn's Disease.Inflamm Bowel Dis2023
36191274The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium.Am J Gastroenterol2023
35880680Increased Expression of Interleukin-13 Receptor in Ileum Associated With Nonresponse to Adalimumab in Ileal Crohn's Disease.Inflamm Bowel Dis2023
33039584Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis.Clin Gastroenterol Hepatol2022
35474325Real-world multicentre observational study including population pharmacokinetic modelling to evaluate the exposure-response relationship of vedolizumab in inflammatory bowel disease: ERELATE Study.Aliment Pharmacol Ther2022
35378331The Host-Microbiome Response to Hyperbaric Oxygen Therapy in Ulcerative Colitis Patients.Cell Mol Gastroenterol Hepatol2022
35798960Enhancing untargeted metabolomics using metadata-based source annotation.Nat Biotechnol2022
35347100Preserved SARS-CoV-2 Vaccine Cell-Mediated Immunogenicity in Patients With Inflammatory Bowel Disease on Immune-Modulating Therapies.Clin Transl Gastroenterol2022
35435862Comparative Effectiveness of Biologics for Endoscopic Healing of the Ileum and Colon in Crohn's Disease.Am J Gastroenterol2022
35595415Dual Advanced Therapies and Novel Pharmacotherapies for Moderately to Severely Active Crohn's Disease.Gastroenterol Clin North Am2022
35391720Digital Therapeutics Care Utilizing Genetic and Gut Microbiome Signals for the Management of Functional Gastrointestinal Disorders: Results From a Preliminary Retrospective Study.Front Microbiol2022
35362140Editorial: is it not just PROs, but the most important individual PRO, that really matters in Crohn's disease? Authors' reply.Aliment Pharmacol Ther2022
35416799Recommendations on the Appropriate Management of Steroids and Discharge Planning During and After Hospital Admission for Moderate-Severe Ulcerative Colitis: Results of a RAND Appropriateness Panel.Am J Gastroenterol2022
36778514Probability of Response as Defined by a Clinical Decision Support Tool Is Associated With Lower Healthcare Resource Utilization in Vedolizumab-Treated Patients With Crohn's Disease.Crohns Colitis 3602022
36503356Stool multi-omics for the study of host-microbe interactions in inflammatory bowel disease.Gut Microbes2022
36866030Using a Clinical Decision Support Tool for Inflammatory Bowel Disease.Gastroenterol Hepatol (N Y)2022
36531445Development of Inflammatory Bowel Disease in HIV Patients: A Danish Cohort Study (1983-2018) With American Validation (1999-2018).Gastro Hep Adv2022
35973139Effect of Obesity on Risk of Hospitalization, Surgery, and Serious Infection in Biologic-Treated Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study.Am J Gastroenterol2022
35999575Location-specific signatures of Crohn's disease at a multi-omics scale.Microbiome2022
36013186Mental Health Symptom Reduction Using Digital Therapeutics Care Informed by Genomic SNPs and Gut Microbiome Signatures.J Pers Med2022
33766910Predicting endoscopic remission in Crohn's disease by the modified multiplier SES-CD (MM-SES-CD).Gut2022
33640480Comparative Risk of Serious Infections With Tumor Necrosis Factor α Antagonists vs Vedolizumab in Patients With Inflammatory Bowel Diseases.Clin Gastroenterol Hepatol2022
33838348Comparative Efficacy and Rapidity of Action for Infliximab vs Ustekinumab in Biologic Naïve Crohn's Disease.Clin Gastroenterol Hepatol2022
  • 1 - 50 of 216

Recommended Authors

Kathleen M Andersen
Collegeville
Career Start Year 2015
Number of shared co-authors 0
Donevan Westerveld
New York-Presbyterian Hospital/Weill Cornell Medicine
Career Start Year 2014
Number of shared co-authors 0
Terrence C Lee
University of California San Diego
Career Start Year 2013
Number of shared co-authors 0
Anouar Teriaky
Western University
Career Start Year 2011
Number of shared co-authors 3
Trilokesh D Kidambi
City of Hope National Medical Center
Career Start Year 2010
Number of shared co-authors 0
Brendan Boyle
Nationwide Children's Hospital
Career Start Year 2009
Number of shared co-authors 4
Shailja C Shah
University of California San Diego, Veterans Affairs San Diego Healthcare System
Career Start Year 2009
Number of shared co-authors 9
Joseph J Larson
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2009
Number of shared co-authors 2
Rafia Bhore
Regeneron Pharmaceuticals
Career Start Year 2009
Number of shared co-authors 0
Ajitha Mannalithara
Stanford University School of Medicine
Career Start Year 2008
Number of shared co-authors 0
Elizabeth Esterberg
RTI Health Solutions
Career Start Year 2008
Number of shared co-authors 0
Craig W Newcomb
University of Pennsylvania Perelman School of Medicine
Career Start Year 2007
Number of shared co-authors 0
Jessica J Lee
Center for Drug Evaluation and Research
Career Start Year 2006
Number of shared co-authors 3
Michael Sey
Western University
Career Start Year 2006
Number of shared co-authors 3
Daniel J Stein
Brigham and Women's Hospital
Career Start Year 2005
Number of shared co-authors 0
Martijn G H van Oijen
University of Amsterdam, Cancer Center Amsterdam
Career Start Year 2004
Number of shared co-authors 4
Harry Sokol
Paris Center for Microbiome Medicine
Career Start Year 2004
Number of shared co-authors 6
Ashish Atreja
Icahn School of Medicine at Mount Sinai
Career Start Year 2003
Number of shared co-authors 11
Florian Grimpen
Royal Brisbane and Women's Hospital
Career Start Year 2000
Number of shared co-authors 0
Ajay Bansal
Regeneron Pharmaceuticals Inc.
Career Start Year 2000
Number of shared co-authors 0
Uri Ladabaum
Stanford University School of Medicine
Career Start Year 1998
Number of shared co-authors 1
William A Faubion
Mayo Clinic
Career Start Year 1997
Number of shared co-authors 12
Kevin P Rioux
University of Calgary, 0 Hospital Drive NW
Career Start Year 1992
Number of shared co-authors 0
Brennan M R Spiegel
Cedars-Sinai Center for Outcomes Research and Education (CS-CORE)
Career Start Year 1992
Number of shared co-authors 13
Joseph A Murray
Mayo Clinic
Career Start Year 1991
Number of shared co-authors 10
Cathie Spino
University of Michigan ann arbor
Career Start Year 1991
Number of shared co-authors 0
Susan Mallett
University College London (UCL)
Career Start Year 1990
Number of shared co-authors 0
Peter Richardson
Section of Health Services Research, Baylor College of Medicine
Career Start Year 1989
Number of shared co-authors 1
Athos Bousvaros
Boston Children's Hospital
Career Start Year 1985
Number of shared co-authors 6
Felicity T Enders
Mayo Clinic
Career Start Year 1985
Number of shared co-authors 5

Collaborators

William J Sandborn
University of California San Diego
Co-authored papers 109
Siddharth Singh
University of California San Diego
Co-authored papers 85
Brigid S Boland
University of California
Co-authored papers 54
Vipul Jairath
Schulich school of Medicine, Western University.
Co-authored papers 54
Neeraj Narula
Farncombe Family Digestive Health Research Institute, McMaster University
Co-authored papers 43
Jean-Frederic Colombel
Icahn School of Medicine at Mount Sinai
Co-authored papers 29
Corey A Siegel
Dartmouth-Hitchcock Medical Center
Co-authored papers 25
Edward V Loftus
Mayo Clinic College of Medicine and Science
Co-authored papers 16
David Hudesman
NYU Grossman School of Medicine
Co-authored papers 15
Bruce E Sands
Icahn School of Medicine at Mount Sinai
Co-authored papers 15
Dana J Lukin
Jill Roberts Center for IBD
Co-authored papers 13
Sunanda V Kane
Mayo Clinic
Co-authored papers 13
Eugenia Shmidt
University of Minnesota
Co-authored papers 12
Arun Swaminath
Lenox Hill Hospital
Co-authored papers 12
John T Chang
University of California San Diego
Co-authored papers 11
Robert Hirten
Co-authored papers 11
Nghia H Nguyen
University of California
Co-authored papers 11
Mark A Valasek
Co-authored papers 9
Sonia Ramamoorthy
University of California
Co-authored papers 7
Ronghui Xu
University of California San Diego
Co-authored papers 6
Lucila Ohno-Machado
Escola de Administracao de Empresas - FGV, Stanford University, University of California San Diego, University of Sao Paulo, Yale School of Medicine
Co-authored papers 6
Lucila Ohno-Machado
Co-authored papers 6
Mohammad Hassan Murad
Evidence Foundation
Co-authored papers 6
Rohit Loomba
Co-authored papers 6
Pieter C Dorrestein
Co-authored papers 5
Khadija Chaudrey
Lahey Hospital and Medical Center
Co-authored papers 5
Qiyun Zhu
Biodesign Center for Fundamental and Applied Microbiomics, Arizona State University
Co-authored papers 5
Samuel Eisenstein
University of California San Diego
Co-authored papers 5
Farhad Peerani
University of Alberta
Co-authored papers 5
James A Proudfoot
Shiley Eye Institute, University of California
Co-authored papers 5
Release 1.2